LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago

The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is the most common genetic determinant of Parkinson disease (PD) identified to date. It accounts for 1%–7% of PD in patients of European origin and 20%–40% in Ashkenazi Jews and North African Arabs with PD. Previous studies concluded that pati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zabetian, Cyrus P., Hutter, Carolyn M., Yearout, Dora, Lopez, Alexis N., Factor, Stewart A., Griffith, Alida, Leis, Berta C., Bird, Thomas D., Nutt, John G., Higgins, Donald S., Roberts, John W., Kay, Denise M., Edwards, Karen L., Samii, Ali, Payami, Haydeh
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Human Genetics 2006
Témata:
Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1592578/
https://ncbi.nlm.nih.gov/pubmed/16960813
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky